梅花生物（600873）8月1日主力资金净流出3776.14万元

Group 1 - The core viewpoint of the news is that Meihua Biological (600873) has shown a decline in stock price and mixed financial performance, with a notable increase in net profit despite a decrease in total revenue [1][3] - As of August 1, 2025, Meihua Biological's stock closed at 11.16 yuan, down 0.8%, with a trading volume of 260,100 hands and a transaction amount of 292 million yuan [1] - The company's latest quarterly report indicates total revenue of 6.269 billion yuan, a year-on-year decrease of 3.36%, while net profit attributable to shareholders reached 1.019 billion yuan, a year-on-year increase of 35.52% [1] Group 2 - Meihua Biological has made investments in 20 companies and participated in 71 bidding projects, indicating active engagement in business expansion [2] - The company holds 91 trademark registrations and 18 patents, showcasing its commitment to intellectual property [2] - Meihua Biological has 40 administrative licenses, reflecting its compliance and operational capabilities in the industry [2]